Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca.

NCT02472964 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: Trastuzumab
BIOLOGICAL: MYL- 1401O
DRUG: Paclitaxel
DRUG: Docetaxel

Sponsor

Mylan Inc.

Collaborators

[object Object]